We prepared porous poly(ε-caprolactone)/poly(lactic-co-glycolic acid) (PCL/PLGA) 3D scaffolds with surfaces that were modified through the co-precipitation of calcium phosphate (CAP) with binary drug components, including risedronate (RSD) and hyaluronic acid (HyA). The 3D porous biodegradable PCL/PLGA scaffolds were fabricated by sintering microspheres prepared with a 30/70 PCL/PLGA blend. The co-precipitation of the CAP coating with binary drug components significantly enhanced the proliferation and differentiation of rat mesenchymal stem cells (rMSCs) on the scaffolds. Although the presence of both HyA and RSD positively improved proliferation and differentiation, HyA and RSD were more effective on osteoblastic proliferation and differentiation, respectively. These results strongly demonstrate that the drug effects on osteoblastic responses were closely interconnected. The two drugs affect rMSCs behavior in a concentration-dependent manner, requiring a balance between proliferation and differentiation for optimal bone regeneration. We expect this surface modification technique could potentially be utilized for the fabrication of functionalized biodegradable scaffolds and delivery of drug mixtures.

본 실험은 bioceramic을 첨가하여 만든 다공성 poly D,L-lactic-co-glycolic acid(PLGA)-scaffold가 인간 지방조직에서 유래된 중간엽 줄기세포(human adipose tissue derived mesenchymal stem cells, ATMSCs)의 골 형성과정에 효과적인지를 알아보고자 수행하였다. ATMSCs를 well plate에 접종하여 골형성 유도(osteogenic induction, OI) 배양액으로